Gabapentin Tablet, Coated
Product Images NDC 50090-7400

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and an acetic acid group (CH2CO2H). This diagram represents the molecular arrangement of the active ingredient gabapentin.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph depicting mean pain scores over an 8-week period for two groups: a placebo group and a gabapentin 3,600 mg/day group. The X-axis shows weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The Y-axis indicates mean pain scores ranging from 0 to 9. The gabapentin group shows a decreasing pain score trend compared to the relatively stable placebo group.*

FDA Label Image

Figure 2 (Gabapenin 03)

Line chart depicting mean pain scores over 7 weeks comparing placebo to gabapentin at doses of 1,800 mg/day and 2,400 mg/day. The x-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart titled 'PHN Studies' comparing percentages for placebo (PBO) and Gabapentin (GBP) at different doses across two studies. Study 1 shows PBO at 12% and GBP 3,600 at 29%. Study 2 shows PBO at 14%, GBP 1,800 at 32%, and GBP 2,400 at 34%. Statistical significance markers (** for p<0.01 and *** for p<0.001) are noted above some bars.*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot comparing percentage difference values against daily doses in mg, showing data from three studies labeled as Study a, Study b, and Study c. The x-axis represents daily dose in mg (600 to 1800 mg), and the y-axis represents the percentage difference (%). Different square markers indicate each study's data points.*

FDA Label Image

Label Image (Lbl500907400)

This is a label for Gabapentin 800 mg coated tablets by A-S Medication Solutions. The label indicates each film-coated tablet contains 800 mg of gabapentin, USP. The product is stored at 77 degrees Fahrenheit and packaged as 60 tablets. The label includes the National Drug Code (NDC) 50090-7400 and packaging details from Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.